Considering this novel ROS-mediated metabolism/stemness perspective in chemoresistant PC, a combinatorial strategy involving inhibition of glycolysis, knockdown of DCLK1, and upregulation of ROS has been proposed to enhance chemosensitivity in PC. This evidence concerns the gene DCLK1 and pachyonychia congenita.